Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 22Carcinoma, Basal Cell 10Uterine Cervical Dysplasia 7Melanoma 7Breast Neoplasms 4Uterine Cervical Neoplasms 3Precancerous Conditions 3Keratosis 3Glioma 3Glioblastoma 3Condylomata Acuminata 3Urinary Bladder Neoplasms 2Squamous Intraepithelial Lesions 2Papillomavirus Infections 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Hutchinson's Melanotic Freckle 2HIV Infections 2Astrocytoma 2Warts 1Vulvar Neoplasms 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sialorrhea 1Sexually Transmitted Diseases 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Temozolomide 13Filgrastim 8Carboplatin 8Radiotherapy 7Magnetic Resonance Spectroscopy 7Etoposide 7Cisplatin 7Cyclophosphamide 6Bevacizumab 6Vincristine 4Thiotepa 4Carmustine 4sargramostim 3Surveys and Questionnaires 3Peripheral Blood Stem Cell Transplantation 3Methotrexate 3Lapatinib 3Irinotecan 3Azacitidine 3veliparib 2alovudine 2aldesleukin 2Tamoxifen 2Radiotherapy, Conformal 2Radiation 2Paclitaxel 2Mental Status and Dementia Tests 2Imatinib Mesylate 2Granulocyte-Macrophage Colony-Stimulating Factor 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ependymoma × Imiquimod × Clear all
NCT01171469 2017-12-02

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
8 enrolled
CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡